Exact Sciences Advances Innovative Cancer Technologies and Approaches Through Visionary Collaborations
Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced separate collaborations with two renowned healthcare organizations at the forefront of cancer research. The...